Article Link: FDA Expands Approved Use of Kalydeco to Treat Additional Mutations of Cystic Fibrosis Source: FDA New Drug Ap...
FDA Approves Merck’s Keytruda (pembrolizumab) as First-Line Combination Therapy for Patients with Metastatic Nonsquamous Non-Small Cell Lung Cancer (NSCLC), Irrespective of PD-L1 Expression
Article Link: FDA Approves Merck’s Keytruda (pembrolizumab) as First-Line Combination Therapy for Patients with Metastatic Nonsquamous Non-Small Cell ...
FDA Grants Accelerated Approval to Bavencio (avelumab) for Urothelial Carcinoma
Article Link: FDA Grants Accelerated Approval to Bavencio (avelumab) for Urothelial Carcinoma Source: FDA New Drug Approval...
FDA Approves Radicava (edaravone) to Treat Amyotrophic Lateral Sclerosis (ALS)
Article Link: FDA Approves Radicava (edaravone) to Treat Amyotrophic Lateral Sclerosis (ALS) Source: FDA New Drug Approvals
AstraZeneca’s Imfinzi (durvalumab) Receives FDA Accelerated Approval for Previously Treated Patients with Advanced Bladder Cancer
Article Link: AstraZeneca’s Imfinzi (durvalumab) Receives FDA Accelerated Approval for Previously Treated Patients with Advanced Bladder Cancer ...
Takeda Announces FDA Accelerated Approval of Alunbrig (brigatinib)
Article Link: Takeda Announces FDA Accelerated Approval of Alunbrig (brigatinib) Source: FDA New Drug Approvals
FDA Approves Tymlos (abaloparatide) for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture
Article Link: FDA Approves Tymlos (abaloparatide) for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture &...
FDA Approves Rydapt (midostaurin) for FLT3-Mutated Acute Myeloid Leukemia and Systemic Mastocytosis
Article Link: FDA Approves Rydapt (midostaurin) for FLT3-Mutated Acute Myeloid Leukemia and Systemic Mastocytosis Source: F...
FDA Approves Brineura (cerliponase alfa) for CLN2 Disease, a Form of Batten Disease
Article Link: FDA Approves Brineura (cerliponase alfa) for CLN2 Disease, a Form of Batten Disease Source: FDA New Drug Appr...
FDA Expands Approved Use of Stivarga (regorafenib) to Treat Hepatocellular Carcinoma
Article Link: FDA Expands Approved Use of Stivarga (regorafenib) to Treat Hepatocellular Carcinoma Source: FDA New Drug App...
